Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score

AIM: TNF inhibitor drugs are a treatment option for rheumatoid arthritis, but response is not universal. Response is typically measured using the composite 4-component (4C) disease activity score 28 (DAS28) which contains more subjective measures. This study used a validated 2-component (2C) DAS28 s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pharmacogenomics
Principais autores: Gilani, Syed SA, Nair, Nisha, Plant, Darren, Hyrich, Kimme, Morgan, Ann W, Morris, Andrew P, Wilson, Anthony G, Isaacs, John D, Barton, Anne, Bluett, James
Formato: Artigo
Idioma:Inglês
Publicado em: Future Medicine Ltd 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7649675/
https://ncbi.nlm.nih.gov/pubmed/33124499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs-2020-0043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados